- Automated implantable cardioverter defibrillators (AICDs) and cardiac resynchronization therapy devices (CRTs) are beneficial in select patients with HF who are at risk for [[Sudden cardiac death]] from ventricular tachyarrhythmias and who have worsening HF from [[cardiac desynchrony]]. 
- [[Automated implantable cardioverter defibrillators]]
- [[cardiac resynchronization therapy devices]] 

|             | AICD                                                                                                                                                                                                                                                                                                               | CRT                                                                                                                                                                                                                    |
| ----------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Indications | prevention of [[Sudden cardiac death]] from tachyarrhythmias caused by [[cardiomyopathy]]                                                                                                                                                                                                                          | [[cardiac desynchrony]]                                                                                                                                                                                                |
| Indications | HFrEF patients with an expected survival of > 1 year and on GDMT with either:<br>- Nonischemic [[Dilated cardiomyopathy]] (DCM) or ischemic heart disease at least 40 days post-MI with LVEF ≤ 35% and NYHA class II–III<br>- Ischemic heart disease at least 40 days post-MI with LVEF ≤ 30% and NYHA class I<br> | LVEF ≤ 35% with NYHA class II–IV symptoms and sinus rhythm OR select patients with AFib PLUS: <br>-QRS duration of > 150 ms with or without LBBB pattern <br>- OR QRS duration of 120–149 ms with LBBB pattern<br><br> |
|             | Any other indication for AICDs                                                                                                                                                                                                                                                                                     | LVEF ≤ 35% requiring pacing for other purposes, e.g., replacement of existing PPM                                                                                                                                      |
|             |                                                                                                                                                                                                                                                                                                                    | LVEF 36–50% with high-risk AV block                                                                                                                                                                                    |
